Search Results

Tisseel [Fibrin Sealant]

Tisseel is a fibrin sealant with a proven history of clinical safety and efficacy that surgeons rely on for use as an adjunct to hemostasis.

Numeta G13E

Numeta G13E 300 mL is the only triple-chamber, ready-to-use parenteral (intravenous) nutrition (PN) product available to treat preterm infants (less than 37 weeks gestation age) who are at high risk for infection and malnutrition5 in the early hours and days of their lives.

HDx Enabled by Theranova

HDx enabled by Theranova is a new dialysis therapy we are pioneering for patients with end-stage renal disease. The Theranova dialyzer features an innovative membrane, which provides an expanded hemodialysis therapy (HDx).

​José (Joe) E. Almeida

José (Joe) E. Almeida is chairman, president and chief executive officer of Baxter International Inc. Every day, millions of patients and caregivers rely on Baxter's broad portfolio of essential healthcare therapies and technologies, which can be found in patient homes, hospitals, physician offices and other sites of care worldwide. 

​K. J. Storm

K. J Storm has served as a director of Baxter since 2003.

​Laura Angelini

Laura Angelini is general manager, Renal Care. Angelini joined Baxter in 2016. Previously, she worked with Johnson & Johnson in roles of increasing responsibility over her 25-year tenure, including as vice president, Medical Devices & Diagnostics, Eastern Europe and most recently as president, North America & Global Franchise Development, Johnson & Johnson Vision Care.

​Jacqueline Kunzler, Ph.D.

Jacqueline (Jackie) Kunzler, Ph.D. is senior vice president, chief quality officer. Kunzler joined Baxter in 1993 and has served in roles of increasing responsibility across Baxter’s research & development, international marketing, and quality organizations, most recently as senior vice president, chief quality officer.

David S. Wilkes, M.D.

David S. Wilkes, M.D. has served as a director of Baxter since 2021.